|
|
|
By Drug Delivery Leader Live | Carolyn Dorgan, director of technical services at device design consultancy Suttons Creek, lays out the phases and key activities in the development of a combination product or combination therapy. | |
|
|
Design Controls For Drug Delivery Devices | By Fran DeGrazio, executive editor, Drug Delivery Leader | In this article, DeGrazio underscores the importance of design controls in the development of combination products and other drug delivery devices. She explains foundational concepts and fundamental steps including design inputs and outputs, design verification and validation, design review, and change controls. |
|
|
|
| Safely Navigating The Transition From MDD To MDR | Article | West Pharmaceutical Services, Inc. | If devices are integral to positive patient outcomes, device partners must play an integral role to ensure regulatory compliance is achieved in the most effective way. |
|
|
| Design-For-Manufacture Accelerates Device-To-Market | Article | SMC Ltd. | Find out why it is critical that OEMs see and understand the benefits of taking time to build a mold or create automation more robustly to achieve long-term savings and higher annual production. |
|
|
|
|
| Ensuring Effective Viral Vector Production | Article | By Ramesh Koukuntla, FUJIFILM Biotechnologies | To develop a fruitful viral vector manufacturing process and a mutually beneficial relationship between sponsor and CDMO, one must balance cost, quality, and timeline via transparent communication. |
|
|
| Nanoformed API: A Superior Alternative To Solid Dispersions | Article | By Dr. Tamas Solymosi, Nanoform | Cutting-edge nanotechnology is now emerging, able to address bioavailability challenges and deliver higher drug loads in more patient-friendly formats with fewer and smaller pills and easier regimens. |
|
|
|
|
|
|
.png){kind=logo}
